HARTMANN distinctly improved the result of the Group
Interview with CEO Dr. Rinaldo Riguzzi and CFO Norbert Unterharnscheidt
Despite a continuing tense financial situation in the health-care markets, the HARTMANN GROUP was able to increase its sales revenues in the medical core segments by 3.7 % in the fiscal year 2005. The strategic focusing on the areas of Wound Management, Incontinence Management and Operating Theater Management improved the profitability of the Heidenheim-based health care company. The result of the Group amounted to EUR 39.6 million, compared to EUR -36.4 million the previous year. HARTMANN considers itself fit for additional growth on the basis of the further expansion of the positioning as a solution partner.
